Vaxart (VXRT) Ratios
Vaxart Ratios
MX:VXRT's free cash flow for Q2 2026 was $2.74M. For the 2026 fiscal year, MX:VXRT's free cash flow was decreased by $-35.00K and operating cash flow was $2.78M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.57 | 0.75 | 3.32 | 5.55 | 15.69 |
| Quick Ratio | 1.57 | 0.75 | 3.32 | 5.55 | 15.69 |
| Cash Ratio | 0.62 | 0.28 | 2.53 | 2.46 | 13.33 |
| Solvency Ratio | 0.25 | -0.54 | -2.17 | -2.36 | -2.02 |
| Operating Cash Flow Ratio | 0.09 | -0.49 | -5.13 | -5.29 | -5.55 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -11.03 | -18.53 | -997.67 | -71.57 |
| Net Current Asset Value | $ 37.84M | $ -39.20M | $ 11.51M | $ 56.20M | $ 135.53M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.14 | 0.29 | 0.18 | 0.11 |
| Debt-to-Equity Ratio | 0.10 | 0.40 | 0.46 | 0.25 | 0.13 |
| Debt-to-Capital Ratio | 0.09 | 0.28 | 0.31 | 0.20 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.03 | 0.04 | 0.05 | 0.05 |
| Financial Leverage Ratio | 2.12 | 2.82 | 1.59 | 1.39 | 1.18 |
| Debt Service Coverage Ratio | 9.82 | -7.84 | -13.79 | -71.89 | -28.74 |
| Interest Coverage Ratio | 6.40 | -22.33 | -57.60 | -87.81 | -49.16 |
| Debt to Market Cap | 0.00 | 0.02 | 0.02 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.05 | 0.05 | 0.06 | 0.06 | 0.05 |
| Net Debt to EBITDA | -1.59 | 0.04 | 0.11 | 0.16 | 1.79 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | 39.02% | 100.00% | -5365.13% |
| EBIT Margin | 8.27% | -222.02% | -1094.42% | -99426.17% | -7722.31% |
| EBITDA Margin | 11.89% | -191.18% | -977.54% | -94000.93% | -7449.66% |
| Operating Profit Margin | 7.62% | -230.99% | -1129.52% | -107090.65% | -8156.05% |
| Pretax Profit Margin | 7.08% | -232.36% | -1114.03% | -100645.79% | -7888.23% |
| Net Profit Margin | 6.88% | -233.27% | -1117.56% | -100708.41% | -7900.22% |
| Continuous Operations Profit Margin | 6.88% | -233.27% | -1117.56% | -100708.41% | -7900.22% |
| Net Income Per EBT | 97.17% | 100.39% | 100.32% | 100.06% | 100.15% |
| EBT Per EBIT | 92.97% | 100.60% | 98.63% | 93.98% | 96.72% |
| Return on Assets (ROA) | 8.77% | -40.24% | -89.80% | -70.04% | -31.86% |
| Return on Equity (ROE) | 18.60% | -113.62% | -142.66% | -97.43% | -37.58% |
| Return on Capital Employed (ROCE) | 18.20% | -87.79% | -106.71% | -84.30% | -34.58% |
| Return on Invested Capital (ROIC) | 17.17% | -80.21% | -98.50% | -82.88% | -34.28% |
| Return on Tangible Assets | 9.13% | -42.29% | -99.32% | -74.67% | -34.20% |
| Earnings Yield | 20.26% | -20.75% | -29.55% | -23.04% | -2.31% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.62 | 2.40 | 2.45 | 5.35 | 12.56 |
| Payables Turnover | 0.00 | 0.00 | 2.84 | 0.00 | 12.59 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 14.07 | 0.99 | 0.20 | 0.00 | 0.05 |
| Asset Turnover | 1.28 | 0.17 | 0.08 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 17.74 | 6.24 | 0.13 | 0.00 | 0.01 |
| Cash Conversion Cycle | 78.99 | 152.22 | 20.31 | 68.22 | 0.06 |
| Days of Sales Outstanding | 78.99 | 152.22 | 148.79 | 68.22 | 29.05 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 128.48 | 0.00 | 28.99 |
| Operating Cycle | 78.99 | 152.22 | 148.79 | 68.22 | 29.05 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.03 | -0.09 | -0.14 | -0.19 | -0.12 |
| Free Cash Flow Per Share | 0.03 | -0.09 | -0.15 | -0.21 | -0.13 |
| Dividend Paid and CapEx Coverage Ratio | 53.20 | -80.80 | -37.66 | -9.87 | -11.60 |
| Capital Expenditure Coverage Ratio | 53.20 | -80.80 | -37.66 | -9.87 | -11.60 |
| Operating Cash Flow Coverage Ratio | 0.86 | -1.92 | -2.66 | -3.46 | -2.44 |
| Operating Cash Flow to Sales Ratio | 0.03 | -1.56 | -9.55 | -885.79 | -67.08 |
| Free Cash Flow Yield | 9.39% | -14.05% | -25.91% | -22.31% | -2.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 5.00 | -4.73 | -3.38 | -4.34 | -43.35 |
| Price-to-Sales (P/S) Ratio | 0.34 | 11.24 | 37.82 | 4371.70 | 3425.04 |
| Price-to-Book (P/B) Ratio | 0.92 | 5.48 | 4.83 | 4.23 | 16.29 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 10.65 | -7.12 | -3.86 | -4.48 | -47.01 |
| Price-to-Operating Cash Flow Ratio | 10.45 | -7.21 | -3.96 | -4.94 | -51.06 |
| Price-to-Earnings Growth (PEG) Ratio | -0.03 | 0.27 | 0.15 | -0.08 | -0.39 |
| Enterprise Value Multiple | 1.27 | -5.84 | -3.76 | -4.49 | -44.18 |
| Enterprise Value | 35.77M | 320.67M | 270.86M | 451.18M | 2.94B |
| EV to EBITDA | 1.27 | -5.84 | -3.76 | -4.49 | -44.18 |
| EV to Sales | 0.15 | 11.17 | 36.71 | 4216.64 | 3291.39 |
| EV to Free Cash Flow | 4.73 | -7.08 | -3.75 | -4.32 | -45.18 |
| EV to Operating Cash Flow | 4.64 | -7.16 | -3.84 | -4.76 | -49.07 |
| Tangible Book Value Per Share | 0.35 | 0.10 | 0.10 | 0.21 | 0.35 |
| Shareholders’ Equity Per Share | 0.38 | 0.12 | 0.12 | 0.23 | 0.38 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.03 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 1.03 | 0.06 | 0.02 | 0.00 | 0.00 |
| Net Income Per Share | 0.07 | -0.14 | -0.17 | -0.22 | -0.14 |
| Tax Burden | 0.97 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.86 | 1.05 | 1.02 | 1.01 | 1.02 |
| Research & Development to Revenue | 0.85 | 2.59 | 9.23 | 757.51 | 54.65 |
| SG&A to Revenue | 0.07 | 0.72 | 3.06 | 274.64 | 24.54 |
| Stock-Based Compensation to Revenue | 0.04 | 0.40 | 1.92 | 126.98 | 9.94 |
| Income Quality | 0.47 | 0.67 | 0.85 | 0.88 | 0.85 |
Currency in USD
